Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2024

Month: August

Request Number: A-2024-000122

Request Summary: The name of the company (sponsor) who submitted the Second Semaglutide Abbreviated New Drug Submission (ANDS); and the year and month in which the Second Semaglutide ANDS was accepted for review. Per Health Canada’s Notice: Expansion of the Generic Submissions Under Review List (February 23, 2024).

Disposition: Disclosed in part

Number of pages: 2

Date modified: